Point-of-care Diagnostics (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made. According to our (Global Info Research) latest study, the global POC Diagnostics market size was valued at USD 26410 million in 2022 and is forecast to a readjusted size of USD 48270 million by 2029 with a CAGR of 9.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. In United States, POC Diagnostics key players include Alere, Roche, Abbott Laboratories, Johnson & Johnson, etc. Global top four manufacturers hold a share over 50%. In terms of product, Blood Glucose Testing is the largest segment, with a share over 45%. And in terms of application, the largest application is Clinics, followed by Hospitals, Laboratory, etc. This report is a detailed and comprehensive analysis for global POC Diagnostics market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global POC Diagnostics market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global POC Diagnostics market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global POC Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029 Global POC Diagnostics market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for POC Diagnostics To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global POC Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alere, Roche, Abbott Laboratories, Johnson & Johnson and Siemens Healthcare, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market Segmentation POC Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Blood Glucose Testing Infectious Diseases Testing Cardiac Markers Testing Coagulation Testing Pregnancy and Fertility Testing Blood Gas or Electrolytes Testing Tumor Markers Testing Urinalysis Testing Cholesterol Testing Others Market segment by Application Clinics Hospitals Laboratory Others Major players covered Alere Roche Abbott Laboratories Johnson & Johnson Siemens Healthcare Danaher Bayer Healthcare Beckman Coulter Nipro Diagnostics Bio-Rad Laboratories Nova Biomedical BioMerieux Quidel Helena Laboratories OraSure Technologies Accriva Abaxis Chembio Diagnostics Trinity Biotech Market segment by region, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia) South America (Brazil, Argentina, Colombia, and Rest of South America) Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe POC Diagnostics product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top manufacturers of POC Diagnostics, with price, sales, revenue and global market share of POC Diagnostics from 2018 to 2023. Chapter 3, the POC Diagnostics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the POC Diagnostics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029. Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029. Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and POC Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029. Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War. Chapter 13, the key raw materials and key suppliers, and industry chain of POC Diagnostics. Chapter 14 and 15, to describe POC Diagnostics sales channel, distributors, customers, research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of POC Diagnostics 1.2 Market Estimation Caveats and Base Year 1.3 Market Analysis by Type 1.3.1 Overview: Global POC Diagnostics Consumption Value by Type: 2018 Versus 2022 Versus 2029 1.3.2 Blood Glucose Testing 1.3.3 Infectious Diseases Testing 1.3.4 Cardiac Markers Testing 1.3.5 Coagulation Tes
